Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian Carcinoma

SIMPLE SUMMARY: A mass spectrometry (MS) proteomics and molecular pathway study was applied to serum samples of patients with ovarian serous carcinoma administered the FOLFOX-4 drug combination protocol, before the second cycle of therapy. This exploratory study aimed at identifying a protein panel...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Arca, Domenico, Severi, Leda, Ferrari, Stefania, Dozza, Luca, Marverti, Gaetano, Magni, Fulvio, Chinello, Clizia, Pagani, Lisa, Tagliazucchi, Lorenzo, Villani, Marco, d’Addese, Gianluca, Piga, Isabella, Conteduca, Vincenza, Rossi, Lorena, Gurioli, Giorgia, De Giorgi, Ugo, Losi, Lorena, Costi, Maria Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856519/
https://www.ncbi.nlm.nih.gov/pubmed/36672361
http://dx.doi.org/10.3390/cancers15020412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856519/
https://www.ncbi.nlm.nih.gov/pubmed/36672361
http://dx.doi.org/10.3390/cancers15020412

Ejemplares similares